By CEA
The CEA draws on its fundamental knowledge base and on its technological developments to propose innovative approaches in the fields of diagnostics, therapy and vaccinology. Researchers approach this work from several angles: the search for biomarkers for use in early diagnosis and therapeutic follow-up, the search for targets and the development of new therapeutic (molecule, cell or gene based) or vaccine-based strategies. The efficacy and safety of new treatments are assessed in preclinical studies. This work has the benefit of the CEA’s expertise in leading-edge technologies (high-speed screening, large scale biology, imaging, etc.) and the high-level research infrastructures set up by the CEA (MIRCen and NeurAtris for translational research in neuroscience and biological therapies, NeuroSpin and France Life Imaging for biomedical imaging, and IDMIT for preclinical research in infectiology).
